These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 32668499)

  • 1. Effect of botulinum toxin type A for treating hypertrophic scars: A split-scar, double-blind randomized controlled trial.
    Elshahed AR; Elmanzalawy KS; Shehata H; ElSaie ML
    J Cosmet Dermatol; 2020 Sep; 19(9):2252-2258. PubMed ID: 32668499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Randomized, Placebo-Controlled, Double-Blind, Prospective Clinical Trial of Botulinum Toxin Type A in Prevention of Hypertrophic Scar Development in Median Sternotomy Wound.
    Li YH; Yang J; Liu JQ; Xie ST; Zhang YJ; Zhang W; Zhang JL; Zheng Z; Hu DH
    Aesthetic Plast Surg; 2018 Oct; 42(5):1364-1369. PubMed ID: 30019241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early postoperative treatment of thyroidectomy scars using botulinum toxin: a split-scar, double-blind randomized controlled trial.
    Kim YS; Lee HJ; Cho SH; Lee JD; Kim HS
    Wound Repair Regen; 2014; 22(5):605-12. PubMed ID: 24898579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Botulinum Toxin Type A in Preventing Postoperative Scars and Improving the Cosmetic Appearance of Scars: A Systematic Review and Meta-Analysis.
    Zhang W; Li X; Li X
    J Cutan Med Surg; 2020; 24(6):608-618. PubMed ID: 32608997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial.
    Hu L; Zou Y; Chang SJ; Qiu Y; Chen H; Gang M; Jin Y; Lin X
    Plast Reconstr Surg; 2018 Mar; 141(3):646-650. PubMed ID: 29481395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Postoperative Application of Botulinum Toxin Type A Prevents Hypertrophic Scarring after Epicanthoplasty: A Split-Face, Double-Blind, Randomized Trial.
    Huang RL; Ho CK; Tremp M; Xie Y; Li Q; Zan T
    Plast Reconstr Surg; 2019 Oct; 144(4):835-844. PubMed ID: 31568286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Botulinum Toxin Type A in Improving Scar Quality and Wound Healing: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Guo X; Song G; Zhang D; Jin X
    Aesthet Surg J; 2020 Apr; 40(5):NP273-NP285. PubMed ID: 31155638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of botulinum toxin type A for treating post burn hypertrophic scars and keloid in children: An intra-patient randomized controlled study.
    Tawfik AA; Ali RA
    J Cosmet Dermatol; 2023 Apr; 22(4):1256-1260. PubMed ID: 36718819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of intralesional injection of botulinum toxin type A in hypertrophic scars and keloids: Clinical and pathological study.
    Khatery BHM; Hussein HA; Abd-El-Raheem TA; El Hanbuli HM; Yassen NN
    Dermatol Ther; 2022 Oct; 35(10):e15748. PubMed ID: 36190006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of laser-assisted delivery vs intralesional injection of botulinum toxin A in treatment of hypertrophic scars and keloids.
    Sabry HH; Ibrahim EA; Hamed AM
    Dermatol Ther; 2020 Nov; 33(6):e13980. PubMed ID: 32638463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin to improve results in cleft lip repair: a double-blinded, randomized, vehicle-controlled clinical trial.
    Chang CS; Wallace CG; Hsiao YC; Chang CJ; Chen PK
    PLoS One; 2014; 9(12):e115690. PubMed ID: 25541942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Botulinum toxin type A for the treatment and prevention of hypertrophic scars and keloids: Updated review.
    Kasyanju Carrero LM; Ma WW; Liu HF; Yin XF; Zhou BR
    J Cosmet Dermatol; 2019 Feb; 18(1):10-15. PubMed ID: 30548742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of Nd:YAG laser alone compared with combined Nd:YAG laser with intralesional steroid or botulinum toxin A in the treatment of hypertrophic scars.
    Rahman SHA; Mohamed MS; Hamed AM
    Lasers Med Sci; 2021 Jun; 36(4):837-842. PubMed ID: 32812129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of botulinum toxin type A to improve treatment of facial wounds: a prospective randomised study.
    Ziade M; Domergue S; Batifol D; Jreige R; Sebbane M; Goudot P; Yachouh J
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):209-14. PubMed ID: 23102873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of intralesional injection of botulinum toxin type A injection for hypertrophic scars.
    Elhefnawy AM
    Indian J Dermatol Venereol Leprol; 2016; 82(3):279-83. PubMed ID: 27088929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Efficacy of Corticosteroid and Corticosteroid Combined with Botulinum Toxin Type A in the Treatment of Keloid and Hypertrophic Scars: A Meta-Analysis.
    Liu XG; Zhang D
    Aesthetic Plast Surg; 2021 Dec; 45(6):3037-3044. PubMed ID: 34184094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Efficacy and Safety of Botulinum Toxin Type A Injections in Improving Facial Scars: A Systematic Review and Meta-Analysis.
    Wang W; Liu G; Li X
    Pharmacology; 2022; 107(5-6):241-249. PubMed ID: 35354154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Efficacy and Safety of Early Postoperative Botulinum Toxin A Injection for Facial Scars.
    Lee SH; Min HJ; Kim YW; Cheon YW
    Aesthetic Plast Surg; 2018 Apr; 42(2):530-537. PubMed ID: 29214336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review And Meta-Analysis: Botulinum Toxin A Effect on Postoperative Facial Scar Prevention.
    Yue S; Ju M; Su Z
    Aesthetic Plast Surg; 2022 Feb; 46(1):395-405. PubMed ID: 34609526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of botulinum toxin type A in the prevention and treatment of facial hypertrophic scars: A meta-analysis.
    Lin J; Wang X
    Int Wound J; 2024 Mar; 21(3):e14796. PubMed ID: 38494191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.